Bharat Biotech to begin COVAXIN trial on 2-6 years age group next week
New Delhi: As part of its COVID-19 vaccination trials for children, Bharat Biotech is likely to administer the second dose of Covaxin to children aged between 2 and 6 years next week, sources said on Thursday.
According to sources, children in the above-mentioned age group have already received the first dose of the vaccine.
They added that the second dose of Covaxin has already been administered to children in the age group of 6-12 years at the All India Institute of Medical Sciences (AIIMS) in New Delhi.
AIIMS, Delhi is one of the trial centres for the vaccine for those below 18 years.
As per sources, the results of clinical trials is expected to come in one month after the completion of trials of all age groups.
The trial is conducted in three phases by segregating children into categories according to their age. The first trial was started in the age group of 12-18 years followed by the age group of 6-12 years and 2-6 years which are currently undergoing trials.
Recently, the Centre informed the Delhi High Court that clinical trials of COVID-19 vaccines for children under 18 years of age were to get completed soon.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.